ES2039847T3 - Leche hiperinmune antihipertensiva. - Google Patents

Leche hiperinmune antihipertensiva.

Info

Publication number
ES2039847T3
ES2039847T3 ES198989301918T ES89301918T ES2039847T3 ES 2039847 T3 ES2039847 T3 ES 2039847T3 ES 198989301918 T ES198989301918 T ES 198989301918T ES 89301918 T ES89301918 T ES 89301918T ES 2039847 T3 ES2039847 T3 ES 2039847T3
Authority
ES
Spain
Prior art keywords
hiperinmune
milk
hypertensive
hypertensive milk
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989301918T
Other languages
English (en)
Inventor
Lee R. Beck
Ralph J. Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Application granted granted Critical
Publication of ES2039847T3 publication Critical patent/ES2039847T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)

Abstract

LOS MAMIFEROS HIPERINMUNIZADOS PRODUCEN LECHE QUE CONTIENE UN FACTOR ANTIHIPERTENSIVO. LA LECHE O EL FACTOR AISLADO PUEDE USARSE PARA TRATAR LA HIPERTENSION.
ES198989301918T 1988-02-26 1989-02-27 Leche hiperinmune antihipertensiva. Expired - Lifetime ES2039847T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/161,039 US4879110A (en) 1983-10-27 1988-02-26 Antihypertensive hyperimmune milk, production, composition, and use

Publications (1)

Publication Number Publication Date
ES2039847T3 true ES2039847T3 (es) 1993-10-01

Family

ID=22579548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989301918T Expired - Lifetime ES2039847T3 (es) 1988-02-26 1989-02-27 Leche hiperinmune antihipertensiva.

Country Status (15)

Country Link
US (1) US4879110A (es)
EP (1) EP0330521B1 (es)
JP (1) JP2792973B2 (es)
AT (1) ATE88349T1 (es)
AU (1) AU621604B2 (es)
CA (1) CA1339760C (es)
DE (1) DE68906054T2 (es)
DK (1) DK201590A (es)
ES (1) ES2039847T3 (es)
HK (1) HK1005013A1 (es)
IE (1) IE63032B1 (es)
IL (1) IL89352A (es)
MX (1) MX168997B (es)
NZ (1) NZ228105A (es)
WO (1) WO1989007948A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US6054124A (en) * 1982-06-03 2000-04-25 Stolle Milk Biologics, Inc. Immune suppressive product
US5863561A (en) * 1982-06-03 1999-01-26 Stolle Research & Development Corporation Immune suppressive product
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US5128127A (en) * 1989-02-08 1992-07-07 Stolle Research & Development Corp. Increased protein production in animals
CA2086101C (en) * 1990-07-05 2002-11-19 Lee R. Beck Immune suppressive product from milk
NZ299579A (en) * 1992-06-16 2000-09-29 Stolle Milk Biologics Inc ue of hyperimmune milk to restore decreasing physiologic function
US6056978A (en) * 1992-06-16 2000-05-02 Stolle Milk Biologics, Inc. Use of hyperimmune milk to prevent suppression of T-lymphocyte production
HUP0400589A3 (en) * 2000-11-15 2005-06-28 Fonterra Co Operative Group Colostrum-based composition
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA587849A (en) * 1959-12-01 E. Petersen William Production of protective principle
US2175090A (en) * 1938-06-22 1939-10-03 Lederie Lab Inc Purification of antibody compositions
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
SE337183B (es) * 1967-04-28 1971-07-26 B Selander
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
CH590064A5 (es) * 1973-11-28 1977-07-29 Biokema Sa
CA1007568A (en) * 1973-12-13 1977-03-29 Michael C. Attwell Bovine immunoglobulin isolation process
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US3987161A (en) * 1974-06-19 1976-10-19 The Procter & Gamble Company Composition and method for conditioning hair with hair antiserum
CH625415A5 (en) * 1975-05-20 1981-09-30 Stolle Res & Dev Process for the production of milk with an anticaries action and use thereof for the production of a composition with an anticaries action
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
FR2452881A1 (fr) * 1979-04-04 1980-10-31 Bel Fromageries Procede de preparation de proteines animales ou vegetales, particulierement de lactoproteines, et nouveaux produits ainsi obtenus
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
FR2487642B2 (fr) * 1980-07-31 1985-10-18 Bel Fromageries Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
EP0064103B1 (en) * 1981-04-28 1985-11-06 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
BE901672A (fr) * 1985-02-07 1985-08-07 Oleofina Sa Procede de purification de proteines du lait et de ses derives.
US4684623A (en) * 1985-05-02 1987-08-04 The Board Of Trustees Of The Cetus Corporation Use of tumor necrosis factor as a weight regulator
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization
SE458818B (sv) * 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum

Also Published As

Publication number Publication date
MX168997B (es) 1993-06-16
NZ228105A (en) 1990-10-26
DE68906054D1 (de) 1993-05-27
EP0330521A3 (en) 1990-10-31
HK1005013A1 (en) 1998-12-18
EP0330521B1 (en) 1993-04-21
DE68906054T2 (de) 1993-09-16
IL89352A (en) 1994-06-24
IE890607L (en) 1989-08-26
ATE88349T1 (de) 1993-05-15
CA1339760C (en) 1998-03-17
JPH03505866A (ja) 1991-12-19
EP0330521A2 (en) 1989-08-30
IL89352A0 (en) 1989-09-10
AU621604B2 (en) 1992-03-19
DK201590D0 (da) 1990-08-22
US4879110A (en) 1989-11-07
DK201590A (da) 1990-08-22
JP2792973B2 (ja) 1998-09-03
WO1989007948A1 (en) 1989-09-08
AU3350089A (en) 1989-09-22
IE63032B1 (en) 1995-03-22

Similar Documents

Publication Publication Date Title
ES2039847T3 (es) Leche hiperinmune antihipertensiva.
ATE56968T1 (de) Substituierte oxo-piperazinyl-triazine und uvlicht stabilisierte zubereitungen.
KR910004080A (ko) 변성한 호박산 이미드류
FI872432A (fi) Indirekt kolorimetrisk bestaemning av en analyt i ett prov med hjaelp av ljussignalers foerhaollande.
DE3684557D1 (de) Waferintegrierte halbleiteranordnung.
DE3751535D1 (de) Halbleiterlaser.
DE3850676T2 (de) Hypotensive okulare Mittel.
DE3683316D1 (de) Halbleiteranordnung.
DE3676867D1 (de) Halbleiterlaser.
DE3679108D1 (de) Halbleiteranordnungen.
DE3851451D1 (de) Regelung von Laserdioden.
FI872612A0 (fi) Nytt antihypertensivt aemne.
DE3674959D1 (de) Halbleiterlaser.
DE3667879D1 (de) Halbleiteranordnung.
DE3687102D1 (de) Halbleiterlaser.
DE3688002T2 (de) Halbleiter-laser.
DE3778510D1 (de) Halbleiterlaser.
DE3678471D1 (de) Halbleiterlaser.
DE3689742T2 (de) Halbleiterlaser.
DE3867598D1 (de) Zweipol-halbleiterdiode.
DE3686944D1 (de) Halbleiteranordnung.
DE3683037D1 (de) Halbleiteranordnung.
NL193599B (nl) Direct gekoppelde halfgeleiderschakeling.
DE3855093T2 (de) Bipolarhalbleiteranordnung
DE3782701T2 (de) Halbleiterlaser.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 330521

Country of ref document: ES